ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/04/15 | 3,938 | 3,965 | 3,865 | 3,913 | -47 | -1.2% | 324,800 |
2024/04/12 | 3,930 | 3,978 | 3,921 | 3,960 | +2 | +0.1% | 252,400 |
2024/04/11 | 3,933 | 3,975 | 3,889 | 3,958 | +32 | +0.8% | 387,100 |
2024/04/10 | 3,895 | 3,952 | 3,878 | 3,926 | -14 | -0.4% | 313,600 |
2024/04/09 | 3,959 | 3,974 | 3,900 | 3,940 | +14 | +0.4% | 407,600 |
2024/04/08 | 3,812 | 3,930 | 3,780 | 3,926 | +115 | +3% | 453,300 |
2024/04/05 | 3,820 | 3,836 | 3,773 | 3,811 | -56 | -1.4% | 484,400 |
2024/04/04 | 3,810 | 3,903 | 3,779 | 3,867 | +96 | +2.5% | 433,600 |
2024/04/03 | 3,800 | 3,838 | 3,737 | 3,771 | +16 | +0.4% | 521,300 |
2024/04/02 | 3,801 | 3,825 | 3,721 | 3,755 | -79 | -2.1% | 609,100 |
2024/04/01 | 3,799 | 3,851 | 3,762 | 3,834 | +11 | +0.3% | 659,700 |
2024/03/29 | 3,760 | 3,892 | 3,701 | 3,823 | +60 | +1.6% | 468,700 |
2024/03/28 | 3,800 | 3,825 | 3,745 | 3,763 | -91 | -2.4% | 492,000 |
2024/03/27 | 3,888 | 3,890 | 3,814 | 3,854 | +7 | +0.2% | 446,600 |
2024/03/26 | 3,867 | 3,891 | 3,811 | 3,847 | -44 | -1.1% | 573,900 |
2024/03/25 | 4,049 | 4,082 | 3,891 | 3,891 | -109 | -2.7% | 861,600 |
2024/03/22 | 3,959 | 4,028 | 3,920 | 4,000 | +214 | +5.7% | 981,500 |
2024/03/21 | 3,860 | 3,938 | 3,744 | 3,786 | -4 | -0.1% | 648,600 |
2024/03/19 | 3,634 | 3,809 | 3,611 | 3,790 | +132 | +3.6% | 547,600 |
2024/03/18 | 3,671 | 3,689 | 3,633 | 3,658 | -12 | -0.3% | 328,700 |
2024/03/15 | 3,716 | 3,716 | 3,619 | 3,670 | -52 | -1.4% | 615,100 |
2024/03/14 | 3,725 | 3,731 | 3,653 | 3,722 | +33 | +0.9% | 420,200 |
2024/03/13 | 3,665 | 3,739 | 3,568 | 3,689 | +3 | +0.1% | 751,400 |
2024/03/12 | 3,662 | 3,708 | 3,599 | 3,686 | +2 | +0.1% | 597,700 |
2024/03/11 | 3,600 | 3,744 | 3,583 | 3,684 | +141 | +4% | 1,299,900 |
2024/03/08 | 3,658 | 3,707 | 3,484 | 3,543 | -185 | -5% | 1,763,100 |
2024/03/07 | 3,800 | 3,825 | 3,643 | 3,728 | +462 | +14.1% | 3,606,200 |
2024/03/06 | 3,016 | 3,266 | 3,003 | 3,266 | +500.5 | +18.1% | 2,756,800 |
2024/03/05 | 2,740.5 | 2,771.5 | 2,721 | 2,765.5 | +20.5 | +0.7% | 225,500 |
2024/03/04 | 2,762.5 | 2,769.5 | 2,742 | 2,745 | -16.5 | -0.6% | 229,200 |
2024/03/01 | 2,749 | 2,777.5 | 2,748.5 | 2,761.5 | +1.5 | +0.1% | 195,700 |
2024/02/29 | 2,750 | 2,773 | 2,738 | 2,760 | +7 | +0.3% | 334,600 |
2024/02/28 | 2,750 | 2,758.5 | 2,743.5 | 2,753 | -3 | -0.1% | 202,300 |
2024/02/27 | 2,742 | 2,772.5 | 2,742 | 2,756 | +12.5 | +0.5% | 140,900 |
2024/02/26 | 2,745 | 2,761 | 2,737 | 2,743.5 | +12.5 | +0.5% | 310,500 |
2024/02/22 | 2,737.5 | 2,749.5 | 2,707 | 2,731 | -19 | -0.7% | 345,400 |
2024/02/21 | 2,771 | 2,772.5 | 2,737 | 2,750 | -12 | -0.4% | 175,300 |
2024/02/20 | 2,772 | 2,780 | 2,750 | 2,762 | -4.5 | -0.2% | 199,500 |
2024/02/19 | 2,796 | 2,819.5 | 2,752 | 2,766.5 | -34.5 | -1.2% | 208,900 |
2024/02/16 | 2,796 | 2,829 | 2,787 | 2,801 | +49 | +1.8% | 320,600 |
2024/02/15 | 2,766 | 2,783.5 | 2,735 | 2,752 | -14.5 | -0.5% | 282,700 |
2024/02/14 | 2,838.5 | 2,841.5 | 2,765.5 | 2,766.5 | -64 | -2.3% | 283,800 |
2024/02/13 | 2,820 | 2,833.5 | 2,803 | 2,830.5 | +14.5 | +0.5% | 340,600 |
2024/02/09 | 2,850 | 2,850 | 2,809 | 2,816 | -67.5 | -2.3% | 279,500 |
2024/02/08 | 2,948 | 2,963 | 2,875.5 | 2,883.5 | -50 | -1.7% | 407,200 |
2024/02/07 | 2,876 | 3,009 | 2,850.5 | 2,933.5 | +243.5 | +9.1% | 1,124,800 |
2024/02/06 | 2,692 | 2,711 | 2,662.5 | 2,690 | -5.5 | -0.2% | 195,400 |
2024/02/05 | 2,699 | 2,717.5 | 2,683.5 | 2,695.5 | +4 | +0.1% | 135,500 |
2024/02/02 | 2,682.5 | 2,700 | 2,670 | 2,691.5 | -4 | -0.1% | 165,300 |
2024/02/01 | 2,663.5 | 2,711.5 | 2,663.5 | 2,695.5 | +21 | +0.8% | 242,500 |
151~
200
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ペプチド | 273,800円 | +56.7% | +357.2% | 0.00% | 25.35倍 | 6.04倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム